Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021

Abstract

by Kshea Hale,Jelili Ojodu andSikha Singh
Int. J. Neonatal Screen. 2021, 7(3), 33; https://doi.org/10.3390/ijns7030033 -10 Jan 2022
Cited by 31 | Viewed by 3713
Abstract
Newborn screening (NBS) programs identify newborns at increased risk for genetic disorders, linking these newborns to timely intervention and potentially life-saving treatment. In the United States, the Health and Human Services (HHS) Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) recommends the disorders for state NBS programs to screen. ACHDNC updated the Recommended Uniform Screening Panel to include Spinal Muscular Atrophy (SMA) in July 2018. As of June 2021, 34 state NBS programs had fully implemented SMA newborn screening, and at least 8 programs were pursuing implementation. This article will review current SMA screening processes, considerations, challenges, and status. Full article
(This article belongs to the Special Issue Newborn Screening for Spinal Muscular Atrophy)
► Show Figures
9 pages, 1188 KiB
Open AccessArticle